Verismo therapeutics awarded a scaleready™ g-rex® grant

Philadelphia , sept. 17, 2024 /prnewswire/ -- verismo therapeutics, a clinical-stage car t company developing the novel kir-car platform technology, today announced that it has been awarded a $150,000 g-rex grant by scaleready™.

CAR Ratings Summary

CAR Quant Ranking